SCYX•benzinga•
SCYNEXIS To Present New Data Of Ibrexafungerp For Refractory Vulvovaginal Candidiasis From Ongoing Phase 3 FURI Study At The American College Of Obstetricians And Gynecologists Annual Clinical & Scientific Meeting On May 6
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 4, 2022 by benzinga